Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Piskel Kyle sold 3,115 Adaptive Biotechnologies Corporation shares (Form 4)

Traded May 18, 2026 · Filed May 20, 2026

On May 18, 2026, Piskel Kyle (Chief Financial Officer) sold 3,115 Adaptive Biotechnologies Corporation shares at US$13.04 for US$40,620, leaving 256,725 shares. Filed May 20, 2026 (Form 4).

Sold
3,115 shares
Price
US$13.04
Value
US$40,620
Holding after
256,725 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockSale3,115US$13.04256,725Direct

Source

View original at SEC

Related